318
Participants
Start Date
July 22, 2025
Primary Completion Date
November 30, 2026
Study Completion Date
December 31, 2026
Albendazole
Participants receive albendazole tablets orally at a total daily dose of 10 mg/kg for 7 consecutive days. The daily dose will be administered in two divided doses. If the calculated dose results in a non-integer number of tablets, the dose will be adjusted to the nearest whole tablet as per the physician's recommendation.
Tribendimidine
Patients receive tribendimidine enteric-coated tablets orally at 0.4 g once daily (QD) for 3 consecutive days.
praziquantel
Participants receive praziquantel tablets orally at 25 mg/kg per dose, three times daily (TID) for 2 consecutive days. If the calculated dose results in a non-integer number of tablets, the dose will be adjusted to the nearest whole tablet as per the physician's recommendation.
NOT_YET_RECRUITING
People's Hospital of Guangxi Zhuang Autonomous Region, Nanning
RECRUITING
The First Affiliated Hospital of Guangxi Medical University, Nanning
People's Hospital of Guangxi Zhuang Autonomous Region
OTHER
Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control
OTHER_GOV
First Affiliated Hospital of Guangxi Medical University
OTHER